| 2024-05-24 | OmniAb, Inc. OABI | President and CEO | 240,000 0.2109% | $4.42 | $1.06M | -2.73% | ||
| 2024-03-22 | OmniAb, Inc. OABI | President and CEO | 225,000 0.1948% | $5.19 | $1.17M | -11.04% | ||
| 2023-12-12 | OmniAb, Inc. OABI | Chief Executive Officer | 200,000 0.1722% | $5.05 | $1.01M | +6.15% | ||
| 2023-11-10 | OmniAb, Inc. OABI | President and CEO | 95,000 0.0821% | $4.27 | $405,517 | +22.85% | ||
| 2023-08-14 | OmniAb, Inc. OABI | President and CEO | 45,000 0.0391% | $5.48 | $246,600 | -5.14% | ||
| 2023-06-09 | OmniAb, Inc. OABI | Chief Executive Officer | 115,000 0.1157% | $4.52 | $519,800 | +14.35% | ||
| 2023-05-12 | OmniAb, Inc. OABI | Chief Executive Officer | 440,000 0.4311% | $3.40 | $1.5M | +48% | ||
| 2022-05-13 | Ligand Pharmaceuticals Incorporated LGND | President and COO | 2,500 0.0143% | $82.76 | $206,910 | +21.81% | ||
| 2022-05-02 | Viking Therapeutics, Inc. VKTX | 90,000 0.1144% | $2.47 | $222,390 | +53.75% | |||
| 2021-06-10 | Viking Therapeutics, Inc. VKTX | director | 40,000 0.052% | $5.69 | $227,600 | -11.57% | ||
| 2020-06-30 | Sale | Viking Therapeutics, Inc. VKTX | director | 26,000 0.0365% | $7.35 | $191,100 | -12.83% | |
| 2018-10-01 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 12,000 0.0573% | $273.88 | $3.29M | -56.27% | |
| 2018-09-04 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 12,000 0.056% | $255.01 | $3.06M | -52.36% | |
| 2018-08-17 | Qualigen Therapeutics, Inc. QLGN | director | 19,751 0.0067% | $2.04 | $40,292 | -53.32% | ||
| 2018-05-10 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 8,881 0.0409% | $167.63 | $1.49M | -5.11% | |
| 2018-02-23 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 5,444 0.0255% | $152.98 | $832,824 | +11.33% | |
| 2017-08-09 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 6,100 0.0023% | $9.97 | $60,817 | +21.97% | |
| 2017-05-18 | Qualigen Therapeutics, Inc. QLGN | director | 18,000 0.0006% | $0.62 | $11,155 | -45.94% | ||
| 2017-05-12 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 5,621 0.0024% | $9.97 | $56,041 | +22.53% | |
| 2017-03-02 | Sale | Ligand Pharmaceuticals Incorporated LGND | President and COO | 6,879 0.0032% | $9.97 | $68,584 | +26.14% |